Contact us: +91 9550333722 040 - 40102781
Structured search
India
Choose your country
Different countries will display different contents
Try our best to find the right business for you.
My chemicalbook

Welcome back!

HomeProduct name listLOXAPINE

LOXAPINE

  • Empirical Formula: C18H18ClN3O
  • Molecular Weight: 327.81
  • MDL number: MFCD00242836
LOXAPINE Structural

What is LOXAPINE?

The Uses of LOXAPINE

Loxapine is a more expressed, active antipsychotic than chlorpromazine. Its sedative effect is inferior to that of chlorpromazine. Indications for its use and side effects correspond with those of phenothiazine derivatives. Loxapine is used for treating psychotic disturbances, in particular cases of chronic and severe schizophrenia.

The Uses of LOXAPINE

Tranquilizer (minor).

brand name

Loxitane-C Oral Suspension [as hydrochloride] (Wyeth-Ayerst); Loxitane Intramuscular [as hydrochloride] (Wyeth-Ayerst).

General Description

A dibenzoxazepine derivative in use is loxapinesuccinate, 2-chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f ][1,4]oxazepine succinate (Daxolin). The structural relationshipto the phenothiazine antipsychotics is apparent. Examplesin this group are clothiapine, metiapine, zotepine, and others.They have electron-withdrawing groups at position 2, relativelyclose to the side-chain nitrogen atoms. Loxapine, an effectiveantipsychotic, blocks D2-type receptors and has side effectssimilar to those reported for the phenothiazines. Itsmetabolism involves aromatic hydroxylation to give severalphenolic metabolites that have higher affinity for D2 receptorsthan the parent. It is also N-demethylated to yield amoxapine(an antidepressant drug), which inhibits norepinephrine (NE)neurotransporter to block neuronal NE reuptake.

Clinical Use

Typical antipsychotic:
Treatment of mild to moderate agitation in schizophrenia or bipolar disease

Synthesis

Loxapine, 2-chloro-11-(4-methyl-1-piperazinyl)dibenz [b,f][1,4]exazepine (6.5.3), which is synthesized from 2-(4-chlorophenoxy)anyline. Acylation of the resulting product using ethylchloroformate forms N-ethoxycarbonyl-2-(4-chlorophenoxy)aniline (6.5.2). Treatment of this product with a mixture of phosphorous oxychloride and phosphorous anhydride gives loxapine (6.5.3) [53–55].

Properties of LOXAPINE

pka pKa 6.6 (Uncertain)

Safety information for LOXAPINE

Computed Descriptors for LOXAPINE

Related products of tetrahydrofuran

You may like

  • 3-(4-Bromo-3-methyl-2-oxo-2,3-dihydro-1h-benzo[d]imidazol-1-yl)piperidine-2,6-dione 2304754-51-4 99%+
    3-(4-Bromo-3-methyl-2-oxo-2,3-dihydro-1h-benzo[d]imidazol-1-yl)piperidine-2,6-dione 2304754-51-4 99%+
    2304754-51-4
    View Details
  • 1126-74-5 99%+
    1126-74-5 99%+
    1126-74-5
    View Details
  • 2-Fluoro-6-iodobenzoic acid 99%+
    2-Fluoro-6-iodobenzoic acid 99%+
    111771-08-5
    View Details
  • 120013-39-0 2,3-Dihydro-5,6-dimethoxy-2-(4-piperidinylmethyl)-1H-inden-1-one hydrochloride 99%+
    120013-39-0 2,3-Dihydro-5,6-dimethoxy-2-(4-piperidinylmethyl)-1H-inden-1-one hydrochloride 99%+
    120013-39-0
    View Details
  • 2-pyridineacetonitrile 2739-97-1 99%+
    2-pyridineacetonitrile 2739-97-1 99%+
    2739-97-1
    View Details
  • 4-FORMYL-N-CBZ-PIPERIDINE 99%+
    4-FORMYL-N-CBZ-PIPERIDINE 99%+
    138163-08-3
    View Details
  • ethyl 2-oxo-2,3,9,10-tetrahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline-8(7H)-carboxylate 313544-31-9 99%+
    ethyl 2-oxo-2,3,9,10-tetrahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline-8(7H)-carboxylate 313544-31-9 99%+
    313544-31-9
    View Details
  • 1-Boc-4-cyanopiperidine 91419-52-2 99%+
    1-Boc-4-cyanopiperidine 91419-52-2 99%+
    91419-52-2
    View Details
Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.